Atlas Trials

Atlas Molecular Pharma

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Atlas Molecular Pharma

RecordFirmDate
A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesions Associated With CEP Following Administration of Oral ATL-001 (Ciclopirox Oral Solution) in Participants Aged >18 Years of Age With CEP (NCT07024316)Atlas Molecular Pharma2026-01-29
Study to Assess the Safety and Pharmacokinetics of ATL-001 (Ciclopirox Olamine) in Healthy Volunteers (NCT05647343)Atlas Molecular Pharma2023-03-31

Track Atlas Molecular Pharma automatically

Every clearance here is in the API, with alerts when new ones post.